Unilever Global IP Limited and Unilever IP Holdings B.V. obtained European Patent EP3595621A1 from the EPO on March 25, 2026. The invention relates to an antimicrobial composition comprising thymol or terpineol and an antimicrobial lipid. The patent is classified under multiple IPC categories including A61K (pharmaceutical preparations), A61Q (cosmetic preparations), and A61P (therapeutic activity). The composition is designated for use across 37 European states including Germany, France, the United Kingdom, and other EU member states.

Patent publication is informational; no immediate action is required from manufacturers or other parties. Companies developing antimicrobial products containing thymol or terpineol should review this patent to assess potential licensing requirements or design-around considerations. The patent grants exclusive rights for the stated composition and its applications in cosmetic and pharmaceutical preparations including hair care, skin treatments, and antiseptic products.